ADVERTISEMENT
Posted: Jun 7, 2023

Reproductive health and COVID-19: Dispelling misinformation

COVID-19

A January 10, 2023, article in JAPhA provides counseling points for pharmacists who are trying to help their patients of reproductive age with the questions and concerns they may have related to COVID-19 and COVID-19 vaccines in this time of misinformation and disinformation.

Read more
Posted: May 9, 2023

Updates from FDA

New & Approved

Updates from FDA

Read more
Posted: May 9, 2023

Beat the bloat and gas

OTCs Today

Everyone has gas; producing and passing gas is a normal part of the digestion process.

Read more
Posted: May 9, 2023

Arnica: Relief from aches and pains?

On The Shelf

Patients suffering from joint and muscle pain often turn to complementary and alternative medicine for relief. Arnica has a long history in treating numerous medical conditions such as insect bites, bruises, scars, fever, apprehension, sciatica, and rash, but it’s primarily recommended for inflammation, arthritis, muscle aches, and stiffness. So, what does the science say?

Mickie Cathers

Read more
Posted: May 9, 2023

FDA approves Brenzavvy for type 2 diabetes

New Drugs

In January of this year, FDA approved Brenzavvy (bexagliflozin—TheracosBio), a sodium-glucose cotransporter 2 (SGLT-2) inhibitor, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes (T2D). Brenzavvy is the fifth SGLT-2 inhibitor to become FDA approved.

Lauren Howell, PharmD

Read more
First3637383941434445Last

Related Articles

Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT